Astera Labs insider filing to sell shares. The Form 144 discloses an intended sale of 94,971 shares of common stock tied to the vesting of restricted stock units on 02/15/2026. The filing lists a prior sale of 90,459 shares on 11/17/2025.
Astera Labs disclosed a proposed sale of 94,971 shares of common stock tied to the vesting of restricted stock units on 02/15/2026. The filing also shows a prior sale of 90,459 shares on 11/17/2025 reported by Jitendra Mohan. The notice lists the transaction as an issuer-related vesting event.
Astera Labs, Inc. reported an equity award for its Chief Financial Officer, Tate Michael Truett. On February 6, 2026, he received 11,787 restricted stock units of Common Stock at a price of $0 per share, increasing his directly held Common Stock to 204,084 shares.
The RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, conditioned on his continued service. Separately, 450,281 Common Stock shares are held indirectly by the Tate 1997 Living Trust, where he is a trustee and disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. insider filing shows new equity compensation for a senior executive. President and COO, and director, Gajendra Sanjay received 26,522 restricted stock units (RSUs) of common stock on February 6, 2026 at a stated price of $0.
The RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, contingent on his continued service. Following this award, he directly beneficially owns 1,626,272 common shares. Additional common shares are held through three separate estate-planning trusts, where he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. reported an equity grant to its Chief Executive Officer and director, Mohan Jitendra. On February 6, 2026, he received 26,522 shares of common stock as restricted stock units at $0 per share under the 2024 Stock Option and Incentive Plan.
The RSUs vest as to 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, contingent on continued service. Following this grant, he directly holds 1,547,710 shares of common stock. Additional common shares are held indirectly through a living trust and several estate-planning trusts that are associated with him, for which he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. reported that its General Counsel and Secretary, Philip Mazzara, received an equity award in the form of restricted stock units. On February 6, 2026, he was granted 5,893 RSUs at a price of $0 per share under the 2024 Stock Option and Incentive Plan.
These RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, as long as he continues his service with the company. Each RSU converts into one share of common stock upon vesting, bringing his directly owned common shares to 142,933 after this grant.
Astera Labs, Inc. announced that Chief Financial Officer Michael Tate will retire from the CFO role effective March 2, 2026, and will remain with the company as Strategic Advisor to the CEO until September 1, 2026 under a transition services agreement. The company states there were no disagreements with Mr. Tate and that his retirement is not related to its operations, policies, or practices.
The board appointed Desmond Lynch as the new Chief Financial Officer effective March 2, 2026. His offer letter provides a $500,000 annual base salary, an annual target bonus equal to 95% of base salary, and equity awards comprising $6,000,000 in restricted stock units, a $1,000,000 supplemental RSU grant, and $2,000,000 in performance stock units, all subject to time-based or performance-based vesting and continued employment.
Astera Labs reported a breakout 2025 with rapid AI-driven growth. Fourth-quarter revenue reached $270.6 million, up 17% sequentially and 92% year-over-year, with GAAP gross margin of 75.6% and GAAP net income of $45.0 million, or $0.25 per diluted share.
For full-year 2025, revenue rose 115% year-over-year to $852.5 million, with GAAP net income of $219.1 million and diluted EPS of $1.22. Non-GAAP operating margin was 39.2%, reflecting substantial profitability after excluding stock-based compensation and acquisition costs.
The company is ramping its Scorpio X-Series smart fabric switches with hyperscaler customers, expanding custom NVLink Fusion connectivity, and launching Leo CXL Smart Memory Controllers. For Q1 2026, it guides revenue to $286–$297 million and GAAP diluted EPS of $0.36–$0.38, with non-GAAP EPS of $0.53–$0.54.
Astera Labs, Inc. entered into a Transaction Agreement with Amazon.com, Inc. and issued a Warrant to Amazon.com NV Investment Holdings LLC for up to 3,262,299 shares of common stock at an exercise price of $142.82 per share. The Warrant runs through February 5, 2033 and allows cashless exercise.
Shares under the Warrant vest based on performance conditions tied to specified payment tranches of up to $6.5 billion for Astera Labs’ smart fabric switch, signal conditioning, and optical engine products purchased by Amazon and its affiliates. The deal includes customary anti-dilution adjustments, registration rights, and transfer restrictions, and was structured as an unregistered private offering under Section 4(a)(2) of the Securities Act.
Astera Labs, Inc. reported that Chief Accounting Officer and VP, Finance Cota Germaine received two equity awards on February 2, 2026. The awards total 24,933 restricted stock units (RSUs), each RSU representing one share of common stock.
One grant covers 21,817 RSUs that vest 25% on February 15, 2027, with the remaining 75% vesting in 12 equal quarterly installments afterward, contingent on continued service. A second grant of 3,116 RSUs vests 100% on February 15, 2027, also subject to ongoing service. Following these grants, Germaine directly holds 24,989 shares of common stock.